Human Immunoglobulin (pH4) For Intravenous Injection (Covid-19) Is Proving To Be Effective In The Treatment Of Novel Coronavirus Disease
Human immunoglobulin therapy, sometimes called normal human immunoglobulin treatment, is the administration of a complex combination of immune antibodies to treat certain medical conditions. These include chronic hepatitis, multiple sclerosis, Parkinson's disease, rheumatoid arthritis, Lupus, and other autoimmune disorders. Although this form of therapy has proven successful in many cases, it can cause some serious side effects. The use of human immunoglobulin (pH4) for intravenous injection (COVID-19) has witnessed major success in the treatment of novel coronavirus disease. Intravenous immunoglobulin injections are a more common form of Human Immunoglobulin Therapy, and they are usually given in conjunction with primary immunodeficiency. These types of injections are more efficient than subcutaneous immunoglobulin, as the body is able to absorb the human immunoglobulin immediately. Unlike subcutaneous immunoglobulin, which must be metabolized before entering the body, in v...